Prior to a United States Patent and Trademark Office decision to review its controversial stem cell patents, the Wisconsin Alumni Research Foundation predicted such a review would take place. Now, WARF says it will prove the validity of the three patents, which are being challenged...
Sarbanes-Oxley has been more costly than projected, and has identified more risk within business organizations, but the benefits for reliable financial reporting and investor confidence are undeniable. Still, the challenge is making sure SOX creates more benefits than costs, and according to Guest Columnist Ron...
The business lessons of Abbott Laboratories' humbling defeat to Innogenetics in U.S. District Court pertain to due diligence and better risk management, but the benefits also may include a swifter and more affordable form of justice for more modest biopharm and biotech companies that want...
A number of government laws and regulations require businesses to implement policies, procedures, and training to prevent identity theft. Companies that think they are immune and neglect this potential business risk could face substantial penalties and legal costs, warns guest columnist Joseph Campana....
Pretexting was used to spy on Hewlett Packard's Board of Directors, with the result being the "Exxon Valdez" of the technology sector, writes columnist James Carlini. The recent corporate intrigue offers several lessons in business leadership, not the least of which is what happens when...
The legal challenge to stem cell patents held by the Wisconsin Alumni Research Foundation is nearing the point where the United States Patent and Trademark Office will decide whether to review the validity of the patents. A WARF spokesman expressed confidence that the patents would...
After filing its annual and quarterly reports, Merge Healthcare has received word that it will continue to be listed on the NASDAQ Stock Market. The medical software developer had earlier announced that improper financial reporting was due in part to the bypassing of internal accounting...
An amendment that would allow companies that are majority-owned by venture capital firms to apply for Small Business Innovation Research and Technology Transfer grants is on its way to the U. S. House Small Business Committee. The measure has some worried that these grants will...
Following the most turbulent six-month period in its history, Merge Healthcare, a supplier of medical imaging and information technology, has appointed a new CEO and reported a $215.8 million quarterly loss. Kevin Rardin is the new president and CEO of the financially troubled company, and...
Has Mark Green found a way to defuse the stem cell issue? The Republican gubernatorial candidate has called for $25 million in state funding to develop stem cell research techniques that do not involve the destruction of embryos, a proposal the Doyle campaign calls irresponsible...